Director Mattaj comments on the Nobel Prize for Chemistry 2020
Director Iain Mattaj commented the winners of the 2020 Nobel Prize for Chemistry: “The Nobel prize awarded to Charpentier and Doudna is very well deserved. CRISPR is a typical example of a discovery which initially seemed interesting to a limited, niche group of scientists studying bacterial evolution. It has since become a fundamental tool for biology and subsequently an experimental tool for therapies linked to human health.
Genetic engineering, first achieved in 1972, is the ability to manipulate the structure and composition of DNA molecules by “cutting and pasting”. It allows us to learn what genes do, how they work and why they go wrong.
CRISPR technology has the potential to make the “dream” of genetic engineering come true: to make specific, targeted changes in the genome of any organism.
Since the breakthrough of Charpentier and Doudna, thousands of experiments have been published showing that CRISPR systems work to enable “cut and paste” experiments in the genomes of a large variety of organisms, including human cells and organoids in culture. Off-target side effects are limited and can be measured and controlled. This progress is already enabling clinical trials of the use of CRISPR in certain types of cancer treatment. Once its safety is established, the method will be applicable to many genetic disease states, and also potentially to treat parasites that infect or damage humans, like viruses.
Meanwhile, researchers are applying the method to a wide variety of questions. At Human Technopole for example, we are using it to help understand neurodevelopmental disorders, to identify promising drug targets in different cancers and to understand aspects of the evolution of the brain.”
Image credit: Nobel Media. Ill. Niklas Elmehed.
Share:
You could also like:
-
Head of Computational Biology appointed
Andrea Sottoriva, an internationally renowned computational biologist currently the Director of the Centre for Evolution and Cancer at the Institute of Cancer Research in London will lead Human Technopole’s Computational Biology Research Centre. Andrea was selected through an international call and is still active at his current institute, the Institute of Cancer Research in London. […]
-
HT AND UniTO: BUILDING LONG-TERM SCIENTIFIC COLLABORATION
3 MARCH 2021 | h 10:00 – 11:30 Human Technopole and University of Turin have recently signed a Memorandum of Understanding for scientific collaboration, which paves the way for numerous joint activities. During this virtual event, open to students and researchers at all levels, the two Institutes will kick off the collaboration by presenting their […]
-
Our first buildings for experimental labs
The construction works for Human Technopole’s first experimental laboratories have been completed today. The spaces, known as “incubator labs“, are made up of three high-tech prefabricated buildings, which will allow HT scientists to perform their research activities until the completion of the South Building, scheduled for 2026. The three buildings are positioned next to Palazzo […]
-
HT signs agreement with EneaTech
Human Technopole Foundation (HT) and Enea Tech have signed an agreement to jointly develop possible synergies in the field of scientific research and technology transfer. Among the goals of HT, the Italian institute for the life sciences, there is also the promotion of innovation and progress through technology transfer and the creation of strong relations […]
-
New Group Leaders in Structural Biology
The year is off to a good start for our Structural Biology Research Centre, with the arrival of three new Group Leaders following the open recruitment call which opened in April 2020. Francesca Coscia, an Italian biochemist and Cryo-EM expert currently at the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK. Her research focuses on the […]